Developing novel kidney transplant drug development tools to enhance regulatory decision making and enable innovation in medical product development
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40118C10184
- Awardee
-
The Critical Path Institute UEI KAEPADMRKHD3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,594,872
Award facts
- Opportunity
-
- Broad Agency Announcement Solicitation · FDABAA1800123 · Posted Feb 13, 2018
- Contract value 100% obligated
- $1,594,872.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Tucson, AZ 85718, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $998,184 | |
| Original award | $596,688 |
About this award
This is a definitive contract awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to The Critical Path Institute (C-Path), a non-profit organization. The contract, which does not have a set-aside designation, is for $1,594,872.00 and is for the development of novel kidney transplant drug development tools to enhance regulatory decision making and enable innovation in medical product development. The contract was awarded on September 19, 2018, with a completion date of December 30, 2022. C-Path has previously provided services to the FDA, including developing frameworks, models, and assessments to support the agency's regulatory science and biomarker qualification initiatives. This contract appears to be a continuation of C-Path's work in supporting the FDA's mission to protect and promote the health of the nation through advancing scientific knowledge, as outlined in the original solicitation.
Quick answers
Who was awarded contract 75F40118C10184?
75F40118C10184 was awarded to The Critical Path Institute by Food and Drug Administration (Department of Health and Human Services) on September 19, 2018.
How much is contract 75F40118C10184 worth?
The government has obligated $1,594,872 on 75F40118C10184.
Was contract 75F40118C10184 competed?
The extent of competition for 75F40118C10184 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award